The agency said the gene therapy should remain on the market while it assesses the situation and does not impact their evaluation of data from the human clinical trials.
from Front page feed https://ift.tt/2YuElXQ
from Front page feed https://ift.tt/2YuElXQ
Comments
Post a Comment